For the first time, scientists have 'photographed' a rare plasma instability, where high-energy electron beams form into spaghetti-like filaments. A new study, published in Physical Review Letters ...

The Plasma Burst Laser is a hitscan weapon that operates on durability rather than ammo (plus it packs quite an explosive punch). However, the Plasma Burst Laser isn’t the easiest item to come by.

More than two dozen people rallied on Monday against a new for-profit clinic in Whitby that pays people for plasma donations. Demonstrators marched outside the office of the Grifols Plasma ...

GUB014295 is currently in a Phase 1 clinical trial. A potential long-acting amylin analog, GUB014295 is an agonist that specifically activates amylin and calcitonin receptors. Amylin, a satiety ...

Harrison, whose plasma contained a “rare and precious antibody” known as Anti-D, donated blood more than 1,100 times, according to Australian Red Cross Lifeblood, which confirmed his death in ...

One of the last big phar­ma hold­outs in obe­si­ty has now en­tered what has be­come the most sought-af­ter field in the in­dus­try.

AbbVie ABBV announced that it has entered into a licensing agreement with Denmark-based biotech Gubra for the latter’s experimental obesity drug, GUB014295. This marks the American drugmaker’s ...

Partnership marks AbbVie's entrance into the obesity field Agreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie's global ...

Partnership marks AbbVie’s entrance into the obesity field Agreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie’s global ...

Agreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie's global infrastructure for developing and commercializing therapies for ...

In addition, there will be a $350 million up-front payment as Abbvie takes over the reins of GUB-014295 (referred to as Gubamy), a long-acting analog of the satiety hormone amylin, currently in phase ...